Amicus Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
06.09.24
/
50%
€10.70
Target price
06.09.25
€16.18
Performance (%)
-10.28%
Price
26.09.24
€9.65
Summary
This prediction is currently active. The price of Amicus Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.28%. This prediction currently runs until 06.09.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Amicus Therapeutics Inc. | -1.026% |
iShares Core DAX® | 1.518% |
iShares Nasdaq 100 | 1.240% |
iShares Nikkei 225® | 2.808% |
iShares S&P 500 | 0.403% |
Comments by Jefferies_Financial_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $18.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat